Addiction Medicine — Asia-Pacific | NovaPharmaNews

Breaking

RAPS Euro Convergence 2026: Regulatory News - Day 1 Roundup Heart Failure 2026: Vutrisiran Data & European Pharma News Mifepristone Access Continues Under Supreme Court Hold as Planned Parenthood Responds to 5th Circuit Ruling

Newleos Begins Phase 1b Trial of NTX-2001 for Alcohol Use Disorder Treatment

NewsApr 29, 2026

Newleos Begins Phase 1b Trial of NTX-2001 for Alcohol Use Disorder Treatment

Newleos doses first patient in Phase 1b study of NTX-2001, a TAAR1 partial agonist targeting alcohol use disorder, marking key development milestone.